UniProt ID | AP2B1_MOUSE | |
---|---|---|
UniProt AC | Q9DBG3 | |
Protein Name | AP-2 complex subunit beta | |
Gene Name | Ap2b1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 937 | |
Subcellular Localization |
Cell membrane. Membrane, coated pit Peripheral membrane protein Cytoplasmic side. AP-2 appears to be excluded from internalizing CCVs and to disengage from sites of endocytosis seconds before internalization of the nascent CCV.. |
|
Protein Description | Component of the adaptor protein complex 2 (AP-2). Adaptor protein complexes function in protein transport via transport vesicles in different membrane traffic pathways. Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation. AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome. The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components. Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation. AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis. AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules. AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway. The AP-2 beta subunit acts via its C-terminal appendage domain as a scaffolding platform for endocytic accessory proteins; at least some clathrin-associated sorting proteins (CLASPs) are recognized by their [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif. The AP-2 beta subunit binds to clathrin heavy chain, promoting clathrin lattice assembly; clathrin displaces at least some CLASPs from AP2B1 which probably then can be positioned for further coat assembly (By similarity).. | |
Protein Sequence | MTDSKYFTTNKKGEIFELKAELNNEKKEKRKEAVKKVIAAMTVGKDVSSLFPDVVNCMQTDNLELKKLVYLYLMNYAKSQPDMAIMAVNSFVKDCEDPNPLIRALAVRTMGCIRVDKITEYLCEPLRKCLKDEDPYVRKTAAVCVAKLHDINAQMVEDQGFLDSLRDLIADSNPMVVANAVAALSEISESHPNSNLLDLNPQNINKLLTALNECTEWGQIFILDCLSNYNPKDDREAQSICERVTPRLSHANSAVVLSAVKVLMKFLELLPKDSDYYNMLLKKLAPPLVTLLSGEPEVQYVALRNINLIVQKRPEILKQEIKVFFVKYNDPIYVKLEKLDIMIRLASQANIAQVLAELKEYATEVDVDFVRKAVRAIGRCAIKVEQSAERCVSTLLDLIQTKVNYVVQEAIVVIRDIFRKYPNKYESIIATLCENLDSLDEPDARAAMIWIVGEYAERIDNADELLESFLEGFHDESTQVQLTLLTAIVKLFLKKPSETQELVQQVLSLATQDSDNPDLRDRGYIYWRLLSTDPVTAKEVVLSEKPLISEETDLIEPTLLDELICHIGSLASVYHKPPNAFVEGSHGIHRKHLPIHHGSTDAGDSPVGTTTTTNLEQPQVIPSQGDLLGDLLNLDLGPPVNVPQVSSMQMGAVDLLGGGLDSLVGQSFIPSSVPATFAPSPTPAVVSSGLNDLFELSTGIGMAPGGYVAPKAVWLPAVKAKGLEISGTFTHRQGHIYMEMNFTNKALQHMTDFAIQFNKNSFGVIPSTPLAIHTPLMPNQSIDVSLPLNTLGPVMKMEPLNNLQVAVKNNIDVFYFSCLIPLNVLFVEDGKMERQVFLATWKDIPNENELQFQIKECHLNADTVSSKLQNNNVYTIAKRNVEGQDMLYQSLKLTNGIWILAELRIQPGNPNYTLSLKCRAPEVSQYIYQVYDSILKN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTDSKYFTT ------CCCCCCCCC | 49.32 | 8571751 | |
2 | Acetylation | ------MTDSKYFTT ------CCCCCCCCC | 49.32 | - | |
4 | Phosphorylation | ----MTDSKYFTTNK ----CCCCCCCCCCC | 21.79 | 26487105 | |
5 | Acetylation | ---MTDSKYFTTNKK ---CCCCCCCCCCCC | 47.39 | 66700873 | |
5 | Malonylation | ---MTDSKYFTTNKK ---CCCCCCCCCCCC | 47.39 | 26320211 | |
6 | Phosphorylation | --MTDSKYFTTNKKG --CCCCCCCCCCCCC | 15.31 | 29514104 | |
8 | Phosphorylation | MTDSKYFTTNKKGEI CCCCCCCCCCCCCCE | 26.77 | 29514104 | |
11 | Malonylation | SKYFTTNKKGEIFEL CCCCCCCCCCCEEEH | 61.12 | 26320211 | |
12 | Ubiquitination | KYFTTNKKGEIFELK CCCCCCCCCCEEEHH | 64.94 | - | |
42 | Phosphorylation | KKVIAAMTVGKDVSS HHHHHHHHCCCCHHH | 22.75 | 51460325 | |
70 | Phosphorylation | LELKKLVYLYLMNYA HHHHHHHHHHHHHHH | 10.48 | 26643407 | |
72 | Phosphorylation | LKKLVYLYLMNYAKS HHHHHHHHHHHHHHC | 6.04 | 26643407 | |
76 | Phosphorylation | VYLYLMNYAKSQPDM HHHHHHHHHHCCCCH | 11.05 | 26643407 | |
79 | Phosphorylation | YLMNYAKSQPDMAIM HHHHHHHCCCCHHHH | 38.48 | 26643407 | |
117 | Ubiquitination | MGCIRVDKITEYLCE CCCEEHHHHHHHHHH | 48.98 | - | |
123 | S-palmitoylation | DKITEYLCEPLRKCL HHHHHHHHHHHHHHC | 5.04 | 28526873 | |
131 | Ubiquitination | EPLRKCLKDEDPYVR HHHHHHCCCCCHHHH | 69.42 | - | |
136 | Phosphorylation | CLKDEDPYVRKTAAV HCCCCCHHHHHHHHH | 25.80 | 82611 | |
239 | Phosphorylation | KDDREAQSICERVTP CCHHHHHHHHHHHCC | 35.93 | 29899451 | |
249 | Phosphorylation | ERVTPRLSHANSAVV HHHCCCCCCCCHHHH | 23.10 | 15994067 | |
253 | Phosphorylation | PRLSHANSAVVLSAV CCCCCCCHHHHHHHH | 24.19 | 22807455 | |
258 | Phosphorylation | ANSAVVLSAVKVLMK CCHHHHHHHHHHHHH | 21.29 | - | |
265 | Acetylation | SAVKVLMKFLELLPK HHHHHHHHHHHHCCC | 42.51 | 22826441 | |
265 | Ubiquitination | SAVKVLMKFLELLPK HHHHHHHHHHHHCCC | 42.51 | - | |
272 | Ubiquitination | KFLELLPKDSDYYNM HHHHHCCCCCHHHHH | 70.59 | - | |
276 | Phosphorylation | LLPKDSDYYNMLLKK HCCCCCHHHHHHHHH | 10.74 | 25338131 | |
277 | Phosphorylation | LPKDSDYYNMLLKKL CCCCCHHHHHHHHHH | 10.09 | 25338131 | |
282 | Acetylation | DYYNMLLKKLAPPLV HHHHHHHHHHCCCCC | 41.60 | 23954790 | |
283 | Ubiquitination | YYNMLLKKLAPPLVT HHHHHHHHHCCCCCH | 50.26 | - | |
318 | Acetylation | QKRPEILKQEIKVFF ECCHHHHHHHEEEEE | 52.09 | 22826441 | |
322 | Acetylation | EILKQEIKVFFVKYN HHHHHHEEEEEEECC | 32.03 | 22826441 | |
327 | Acetylation | EIKVFFVKYNDPIYV HEEEEEEECCCCEEE | 32.93 | 22826441 | |
347 | Phosphorylation | DIMIRLASQANIAQV HHHHHHHCCCCHHHH | 34.12 | 20415495 | |
380 | S-palmitoylation | AVRAIGRCAIKVEQS HHHHHHHHEEEHHHH | 3.75 | 26165157 | |
393 | Phosphorylation | QSAERCVSTLLDLIQ HHHHHHHHHHHHHHH | 19.57 | 30993257 | |
394 | Phosphorylation | SAERCVSTLLDLIQT HHHHHHHHHHHHHHH | 15.79 | 29899451 | |
433 | Glutathionylation | ESIIATLCENLDSLD HHHHHHHHHCHHCCC | 2.57 | 24333276 | |
497 | Phosphorylation | KLFLKKPSETQELVQ HHHCCCCHHHHHHHH | 63.25 | 29899451 | |
499 | Phosphorylation | FLKKPSETQELVQQV HCCCCHHHHHHHHHH | 31.51 | 29899451 | |
508 | Phosphorylation | ELVQQVLSLATQDSD HHHHHHHHHHHCCCC | 19.66 | 20415495 | |
538 | Ubiquitination | STDPVTAKEVVLSEK CCCCCCHHHHHHCCC | 41.50 | - | |
599 | Phosphorylation | HLPIHHGSTDAGDSP CCCCCCCCCCCCCCC | 20.82 | 51460333 | |
605 | Phosphorylation | GSTDAGDSPVGTTTT CCCCCCCCCCCCCCC | 22.14 | 30815403 | |
609 | Phosphorylation | AGDSPVGTTTTTNLE CCCCCCCCCCCCCCC | 22.62 | 51460341 | |
707 | Nitration | IGMAPGGYVAPKAVW CCCCCCCEECCCEEE | 10.19 | - | |
719 | Ubiquitination | AVWLPAVKAKGLEIS EEEECCCCCCCEEEE | 46.62 | - | |
726 | Phosphorylation | KAKGLEISGTFTHRQ CCCCEEEEEEEEECC | 23.54 | 19854140 | |
737 | Phosphorylation | THRQGHIYMEMNFTN EECCCEEEEEEECCH | 4.95 | 25367039 | |
743 | Phosphorylation | IYMEMNFTNKALQHM EEEEEECCHHHHHHH | 30.70 | 25367039 | |
751 | Phosphorylation | NKALQHMTDFAIQFN HHHHHHHHHHHHHCC | 26.32 | 19854140 | |
768 | Phosphorylation | SFGVIPSTPLAIHTP CCCCCCCCCEEECCC | 19.57 | 16181353 | |
842 | Acetylation | QVFLATWKDIPNENE EEEEEECCCCCCCCC | 41.23 | 23954790 | |
857 | S-nitrosylation | LQFQIKECHLNADTV EEEEEEEEECCCHHH | 3.62 | 20925432 | |
857 | S-nitrosocysteine | LQFQIKECHLNADTV EEEEEEEEECCCHHH | 3.62 | - | |
878 | Ubiquitination | NNVYTIAKRNVEGQD CCEEEEEECCCCCHH | 40.43 | - | |
878 | Acetylation | NNVYTIAKRNVEGQD CCEEEEEECCCCCHH | 40.43 | 22826441 | |
888 | Phosphorylation | VEGQDMLYQSLKLTN CCCHHHHHHHHHCCC | 6.87 | 75177 | |
915 | Phosphorylation | GNPNYTLSLKCRAPE CCCCEEEEEEECCHH | 20.27 | 23649490 | |
926 | Phosphorylation | RAPEVSQYIYQVYDS CCHHHHHHHHHHHHH | 8.29 | 20415495 | |
928 | Phosphorylation | PEVSQYIYQVYDSIL HHHHHHHHHHHHHHH | 6.23 | 75181 | |
931 | Phosphorylation | SQYIYQVYDSILKN- HHHHHHHHHHHHCC- | 6.61 | 15546519 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AP2B1_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AP2B1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AP2B1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
EPS15_MOUSE | Eps15 | physical | 9182572 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-737 AND TYR-888, ANDMASS SPECTROMETRY. |